Pharmacokinetic Study of SCT800 in Previously Treated Patients With Hemophilia A
Phase 1
- Conditions
- Hemophilia A
- Interventions
- Biological: SCT800Biological: Xyntha
- First Posted Date
- 2016-09-02
- Last Posted Date
- 2016-09-02
- Lead Sponsor
- Sinocelltech Ltd.
- Target Recruit Count
- 16
- Registration Number
- NCT02888223
- Locations
- 🇨🇳
Xiangya Hospital of Centre-South University, Changsha, Hunan, China
A Study Comparing the Efficiency and Safety of S-CHOP(Cyclophosphamide, Hydroxydaunomycin, Oncovin, and Prednisone) Versus R-CHOP in Untreated CD20(Cluster of Differentiation Antigen 20)-Positive DLBCL Patients
Phase 3
- Conditions
- Diffuse Large B Cell Lymphoma
- Interventions
- Drug: SCT400 plus CHOP
- First Posted Date
- 2016-05-16
- Last Posted Date
- 2016-05-16
- Lead Sponsor
- Sinocelltech Ltd.
- Target Recruit Count
- 330
- Registration Number
- NCT02772822
- Locations
- 🇨🇳
Cancer Hospital Chinese Academy of Medical Sciences, Beijing, Beijing, China
A Pharmacokinetic Study Comparing SCT400 And Rituximab in Patients With B-cell Non-Hodgkin's Lymphoma
- First Posted Date
- 2015-05-28
- Last Posted Date
- 2015-05-28
- Lead Sponsor
- Sinocelltech Ltd.
- Target Recruit Count
- 80
- Registration Number
- NCT02456207
- Locations
- 🇨🇳
Cancer Hospital Chinese Academy of Medical Sciences, Beijing, Beijing, China
Safety, Tolerability and Pharmacokinetics of Recombinant Anti-epidermal Growth Factor Receptor(EGFR) Monoclonal Antibody in Patients With Metastatic Colorectal Cancer
Phase 1
- Conditions
- Metastatic Colorectal Cancer
- Interventions
- Biological: Recombinant full human Anti-EGFR Monoclonal Antibody
- First Posted Date
- 2014-08-07
- Last Posted Date
- 2015-04-09
- Lead Sponsor
- Sinocelltech Ltd.
- Target Recruit Count
- 21
- Registration Number
- NCT02211443
Safety, Pharmacokinetics and Pharmacodynamics of Recombinant Chimeric Anti-CD20 Monoclonal Antibody in Patients With B-cell Non-Hodgkin's Lymphoma.
Phase 1
Completed
- Conditions
- B-cell Non Hodgkin's Lymphoma
- Interventions
- Biological: Chimeric anti-CD20 monoclonal antibody
- First Posted Date
- 2014-08-01
- Last Posted Date
- 2014-08-01
- Lead Sponsor
- Sinocelltech Ltd.
- Target Recruit Count
- 15
- Registration Number
- NCT02206308
© Copyright 2025. All Rights Reserved by MedPath